Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-15-000192
Filing Date
2015-02-17
Accepted
2015-02-17 10:05:46
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10Q 2014-12-31 aoxing.htm 10-Q 534850
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh311.htm EX-31.1 9075
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh312.htm EX-31.2 8996
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh321.htm EX-32.1 5392
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh322.htm EX-32.1 5003
  Complete submission text file 0001096906-15-000192.txt   3087596

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axn-20141231.xml EX-101.INS 400670
7 XBRL SCHEMA DOCUMENT axn-20141231.xsd EX-101.SCH 28612
8 XBRL CALCULATION LINKBASE DOCUMENT axn-20141231_cal.xml EX-101.CAL 21616
9 XBRL DEFINITION LINKBASE DOCUMENT axn-20141231_def.xml EX-101.DEF 30727
10 XBRL LABELS LINKBASE DOCUMENT axn-20141231_lab.xml EX-101.LAB 138942
11 XBRL PRESENTATION LINKBASE DOCUMENT axn-20141231_pre.xml EX-101.PRE 125524
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 15618743
SIC: 2834 Pharmaceutical Preparations